Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-12

FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original abbreviated new drug application for piperacillin and tazobactam, a combination antibiotic manufactured by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin and tazobactam (Piperacillin and tazobactam)

Snippet

ORIG AP for PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM)